Keywords
Last Name
Institution

Joshua Matthew Rhett

Title
InstitutionMedical University of South Carolina
DepartmentPharmacology Allocation & Reserves
AddressP.O. Box MSC 509
HCC 702
Hollings Cancer Center - 86 Jonathan Lucas St.
Phone843-792-2277
Fax843-792-2475
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    2002 - PresMember of Sigma Xi
    2003 - 2004GAANN Fellow, Medical University of South Carolina
    2005 - 2007T32 Grantee in Cardiovascular Research, Medical University of South Carolina
    2008 - 2010South Carolina Space Grant Consortium Fellow, Medical University of South Carolina
    2009 - PresMember of American Heart Association
    2011Cover article in Molecular Biology of the Cell
    20111st place for oral presentation in the Postdoc-Resident-Fellow category, MUSC Student Research Day
    2012Cover article in Heart Rhythm
    2013Cover article in Trends in Cardiovascular Medicine
    20131st place for oral presentation in the Postdoc category, MUSC Dept of Surg Research Appreciation Day
    2014Featured article in Tissue Engineering Part B, Reviews
    2014 - PresSouth Carolina Translational Research Grantee

    Collapse Overview 
    Collapse overview
    My work is aimed at elucidating the role that connexin channels play in ATP signaling during injuries. We hypothesize that microvascular endothelial cells near an injury release ATP, and attract inflammatory cells to wounded tissue. Although inflammation is a necessary component of wound healing, inflammatory cells can cause tissue damage. Understanding the molecular mechanisms behind this process could lead to therapies directed at dampening the inflammatory response during wound resolution, and improve the foreign body response to implanted materials and tissues.
    Collapse keywords
    Wound Healing and the Foreign Body Response, Connexin Proteins and Cell-Cell Communication, Purinergic Signaling

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rhett JM, Yeh ES. The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response. Int J Mol Sci. 2018 Mar 30; 19(4). PMID: 29601539.
      View in: PubMed
    2. Grek CL, Rhett JM, Bruce JS, Ghatnekar GS, Yeh ES. Connexin 43, breast cancer tumor suppressor: Missed connections? Cancer Lett. 2016 Apr 28; 374(1):117-126. PMID: 26884256.
      View in: PubMed
    3. Rhett JM, Wang H, Bainbridge H, Song L, Yost MJ. Connexin-Based Therapeutics and Tissue Engineering Approaches to the Amelioration of Chronic Pancreatitis and Type I Diabetes: Construction and Characterization of a Novel Prevascularized Bioartificial Pancreas. J Diabetes Res. 2016; 2016:7262680. PMID: 26788521.
      View in: PubMed
    4. Grek CL, Rhett JM, Bruce JS, Abt MA, Ghatnekar GS, Yeh ES. Targeting connexin 43 with a-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1. BMC Cancer. 2015 Apr 03; 15:296. PMID: 25881004.
      View in: PubMed
    5. Calder BW, Matthew Rhett J, Bainbridge H, Fann SA, Gourdie RG, Yost MJ. Inhibition of connexin 43 hemichannel-mediated ATP release attenuates early inflammation during the foreign body response. Tissue Eng Part A. 2015 Jun; 21(11-12):1752-62. PMID: 25760687.
      View in: PubMed
    6. Grek CL, Rhett JM, Ghatnekar GS. Cardiac to cancer: connecting connexins to clinical opportunity. FEBS Lett. 2014 Apr 17; 588(8):1349-64. PMID: 24607540.
      View in: PubMed
    7. Rhett JM, Fann SA, Yost MJ. Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues. Tissue Eng Part B Rev. 2014 Oct; 20(5):392-402. PMID: 24279914.
      View in: PubMed
    8. Rhett JM, Gourdie RG. The perinexus: a new feature of Cx43 gap junction organization. Heart Rhythm. 2012 Apr; 9(4):619-23. PMID: 21978964.
      View in: PubMed
    9. Palatinus JA, Rhett JM, Gourdie RG. Enhanced PKCe mediated phosphorylation of connexin43 at serine 368 by a carboxyl-terminal mimetic peptide is dependent on injury. Channels (Austin). 2011 May-Jun; 5(3):236-40. PMID: 21532342.
      View in: PubMed
    10. Choi, E., Knight, J.D., Malatanos, M.D., Rhett, J.M., Walters, M.J., Dunn, S.P., Beam, C.F. Preparation of 4,5-Dihydronaphth[2,1-c]isoxazoles from Dilithiated 2-Tetralone Oxime and Select Esters. Synthetic Communications. 2008; (38):713-22.
    11. Gourdie RG, Ghatnekar GS, O'Quinn M, Rhett MJ, Barker RJ, Zhu C, Jourdan J, Hunter AW. The unstoppable connexin43 carboxyl-terminus: new roles in gap junction organization and wound healing. Ann N Y Acad Sci. 2006 Oct; 1080:49-62. PMID: 17132774.
      View in: PubMed
    12. Dillon, R.T., Wethington, A.R., Rhett, J.M., Smith, T.P. Populations of the European freshwater pulmonate Physa acuta are not reproductively isolated from American Physa heterostropha or Physa integra. Invertebrate Biology. 2002; (121):226-234.
    13. Hengst W, Mosler D. [Critical evaluation of liver function tests, using 131 I bromsulphan and bromphthaline]. Fortschr Geb Rontgenstr Nuklearmed. 1973 Mar; 118(3):330-5. PMID: 4691620.
      View in: PubMed
    Rhett's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description